Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel loading dose and brachial flow-mediated vasodilation in stable coronary artery disease
ISRCTN17892444Phase 4Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Johannes Gutenberg University Mainz. Primary endpoint: Absolute change in flow-mediated dilation. Started Mar 2005; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ISRCTN17892444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17892444.